tailieunhanh - Complete response to the combination of Lenvatinib and Pembrolizumab in an advanced hepatocellular carcinoma patient: A case report

The majority of patients diagnosed with hepatocellular carcinoma (HCC) have advanced diseases and many are not eligible for curative therapies. | Complete response to the combination of Lenvatinib and Pembrolizumab in an advanced hepatocellular carcinoma patient A case report

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN